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 Introduction 
 The lumen of the ER provides a unique oxidizing environment 
for protein folding and modifi cation. One third of all newly 
synthesized proteins are translocated into the ER and processed 
by multiple ER resident enzymes. An elaborate quality-control 
system monitors the conformational state of the nascent pro-
teins and retains them in the ER during the folding process 
( Ellgaard and Helenius, 2003 ). Upon correct folding, proteins 
are exported from the ER in coat protein II (COPII) vesicles 
( Lee et al., 2004 ). Although transmembrane proteins can directly 
interact with the cytosolic COPII coat ( Barlowe, 2003 ), some 
soluble luminal proteins require cargo receptors for their se-
lective recruitment into COPII vesicles ( Belden and Barlowe, 
2001 ;  Baines and Zhang, 2007 ). The best characterized mam-
malian cargo receptor is the oligomeric type I membrane lectin 
ERGIC-53 ( Schweizer et al., 1988 ). ERGIC-53 cycles between 
the ER and ER Golgi intermediate compartment (ERGIC), 
captures soluble glycoproteins in the lumen of the ER, and binds 
COPII by means of a dihydrophobic ER export motif in its cyto-
solic tail ( Hauri et al., 2000 ;  Appenzeller-Herzog and Hauri, 
2006 ). As a cargo receptor, ERGIC-53 mediates ER export of 
coagulation factors V and VIII and cathepsin C and Z ( Nichols 
et al., 1998 ;  Vollenweider et al., 1998 ;  Appenzeller et al., 1999 ). 
Furthermore, ERGIC-53 was recently shown to assist the as-
sembly of IgM polymers in the ER ( Anelli et al., 2007 ). With 
only few ERGIC-53 cargo proteins identifi ed, however, it is not 
known whether receptor-mediated ER export is the predominant 
mechanism for the transport of soluble proteins. A major prob-
lem in identifying cargo – receptor complexes is their transient 
nature in a unique ionic and oxidizing environment. Further, 
existing proteomic techniques for identifying protein – protein 
interactions (e.g., affi nity purifi cation/mass spectrometry or the 
yeast two-hybrid system) are not easily applicable or are not ap-
propriate to the study of membrane proteins. However, protein 
fragment complementation assays (PCAs) do allow for detec-
tion of both transient and dynamic protein – protein interactions 
in intact living cells, including those for membrane proteins 
( Remy et al., 1999 ;  Michnick et al., 2007 ). A PCA based on a 
YFP variant (citrine) has been demonstrated to be applicable to 
Secretory proteins are exported from the endo-plasmic reticulum (ER) by bulk ﬂ ow and/or receptor-mediated transport. Our understanding of this 
process is limited because of the low number of identi-
ﬁ ed transport receptors and cognate cargo proteins. 
In mammalian cells, the lectin ER Golgi intermediate com-
partment 53-kD protein (ERGIC-53) represents the best 
characterized cargo receptor. It assists ER export of a 
subset of glycoproteins including coagulation factors V 
and VIII and cathepsin C and Z. Here, we report a novel 
screening strategy to identify protein interactions in the 
lumen of the secretory pathway using a yellow ﬂ uorescent 
protein – based protein fragment complementation assay. 
By screening a human liver complementary DNA library, 
we identify   1-antitrypsin (  1-AT) as previously unrecog-
nized cargo of ERGIC-53 and show that cargo capture is 
carbohydrate- and conformation-dependent. ERGIC-53 
knockdown and knockout cells display a speciﬁ c secretion 
defect of   1-AT that is corrected by reintroducing ERGIC-53. 
The results reveal ERGIC-53 to be an intracellular trans-
port receptor of   1-AT and provide direct evidence for 
active receptor-mediated ER export of a soluble secretory 
protein in higher eukaryotes.
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tagged with YFP2, which localizes YFP2 to the luminal side 
of the membrane and allows screening for protein – protein 
interactions inside the lumen of the ER. Prey proteins were 
C-terminally tagged with YFP1 and expressed from a cDNA-
YFP1 fusion library ( Fig. 1 ). [ID]FIG1[/ID] This fusion orientation assures 
that library-encoded secretory and membrane proteins reach 
the lumen of the ER because N-terminal signal sequences are 
not perturbed. However, we do not expect to identify known 
ERGIC-53 interaction partners with this cDNA-YFP1 library 
because of specifi c characteristics of these proteins or because 
of the specifi c orientation of the prey YFP1 toward cytosol. 
For example, C-terminal tagging cathepsin Z and C impedes 
the interaction with ERGIC-53 ( Nyfeler et al., 2005 ), whereas 
MCFD2-YFP1 is unlikely to be identifi ed because its inter-
action with ERGIC-53 strictly depends on the full-length MCFD2 
protein ( Nyfeler et al., 2008 ). Further, the interaction of 
ERGIC-53 with itself cannot be detected because the oligomeriza-
tion of ERGIC-53 requires its transmembrane domain ( Nufer 
et al., 2003 ), which localizes the YFP1 of all oligomerization-
competent YFP1 – ERGIC-53 prey proteins to the cytosol. This 
compartment-specifi c topological requirement is a unique fea-
ture of the PCA approach, providing information about the ori-
entation of membrane-associated prey proteins. Our C-terminal 
tagging strategy requires that library inserts lack their stop 
protein – protein interactions inside the lumen of the secretory 
pathway ( Nyfeler et al., 2005 ). In the YFP PCA, nonfl uorescent 
N- and C-terminal fragments of YFP (YFP1 and YFP2) are indi-
vidually fused to the coding sequences of two separate proteins 
and expressed in mammalian cells. If the two fusion proteins 
interact, the fragments of YFP are brought into proximity, per-
mitting folding and reconstitution of fl uorescent YFP in vivo. 
Using this specifi c and sensitive assay, we have demonstrated 
that the oligomerization of ERGIC-53 and its interactions with 
multiple coagulation factor defi ciency protein 2 (MCFD2) and 
cathepsin C and Z were readily visible in living cells. Here, we de-
scribe a YFP PCA – based cDNA library screening strategy for the 
identifi cation of novel ERGIC-53 cargo proteins. The screening 
of a human adult liver cDNA library identifi ed   1-antitrypsin 
(  1-AT) as novel interaction partner of ERGIC-53 and our 
validation studies establish ERGIC-53 as a transport receptor 
of   1-AT. 
 Results and discussion 
 Based on a general PCA cDNA library screening strategy ( Remy 
and Michnick, 2004a , b ), we developed a screening approach 
designed to identify proteins that bind to cargo receptors in 
the ER lumen. ERGIC-53 was used as bait and was N-terminally 
 Figure 1.  Strategy of the ERGIC-53 cargo 
hunt based on YFP PCA. (A) Schematic repre-
sentation of the YFP PCA approach to screen 
for ERGIC-53 cargo proteins in the lumen of 
the secretory pathway. YFP PCA is based on 
the reconstitution of functional YFP from two 
nonﬂ uorescent fragments that are brought into 
close proximity by two interacting proteins. 
YFP2 was fused to the ERGIC-53 bait protein, 
whereas YFP1 was fused to a human liver 
cDNA library to express YFP1-tagged prey 
proteins. (B) The YFP2 – ERGIC-53 bait protein 
was expressed from the kanamycin-resistant 
pCMV vector, whereas the cDNA-YFP1 library 
was constructed in the ampicillin-resistant 
pcDNA3 vector. (C) Flow chart of the screen-
ing strategy. 
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The recovery of only 4 positives out of 48 reanalyzed prey 
plasmids is not because of the unspecifi city of our assay but 
rather the uptake of several prey plasmids per transfected cell. 
A YFP-positive cell contains the positive prey plasmid as well 
as many cotransfected negative plasmids, which will be sub-
sequently also recovered (Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200709100/DC1). 
 DNA sequence analysis identifi ed   1-AT as the corre-
sponding cDNA insert in prey plasmids 17, 32, 33, and 44. 
Two types of   1-AT inserts were found, a 1294-bp and a 1297-bp 
variant. Both inserts were in frame and covered the complete 
coding sequence of   1-AT with the exception of the last two 
C-terminal amino acids ( Fig. 2 C ). The ERGIC-53 –  1-AT inter-
action was validated by YFP PCA in HeLa cells using full-
length   1-AT N-terminally tagged with YFP2 ( Fig. 3 A ). [ID]FIG3[/ID]  
  1-AT is a liver glycoprotein of 52 kD carrying three 
N-linked glycans. After its synthesis in hepatocytes,   1-AT is 
secreted into the blood, where it acts as a serine protease inhibitor, 
mainly against neutrophil elastase. As one of the major glyco-
proteins synthesized in the liver,   1-AT is likely to be highly 
abundant in our nonnormalized library. When YFP2 – ERGIC-53 
and the cDNA-YFP1 library were expressed in COS-1 cells 
after siRNA-mediated silencing of   1-AT, a 30 – 50% reduction 
in YFP-positive cells was observed (unpublished data). Hence, 
  1-AT seems responsible for up to half of all observed YFP-
positive cells in our screen. N-linked glycosylation of   1-AT is 
strictly required for its secretion ( Gross et al., 1982 ) and it was 
suggested that the N-glycans may serve as recognition sites for 
an ER-to-Golgi transport receptor ( Lodish and Kong, 1984 ). 
Is ERGIC-53 an intracellular transport receptor of   1-AT? We fi rst 
analyzed the carbohydrate specifi city of the ERGIC-53 –  1-AT 
codon to avoid termination of translation in front of the YFP1 
sequence. To this end, we used cDNAs generated by randomly 
primed reverse transcription of mRNA, which enriches the 
5  ends. cDNA inserts were subcloned from a human adult liver 
cDNA library into mammalian pcDNA3 expression vectors 
containing YFP1 in all three reading frames. The resulting 
cDNA-YFP1 library contained   10 6 clones and inserts ranged 
from   1 to   2.5 kb in size. As expected for a library generated 
from a secretory tissue like liver, cDNAs encoding secretory 
proteins were well represented (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200709100/DC1). 
 The YFP PCA – based cDNA library screen was performed 
in COS-1 cells, which express the large T antigen and replicate 
plasmids containing the SV40 eukaryotic origin of replication. 
Because of this feature, cDNA-YFP1 library plasmids will be 
replicated upon transfection, which ensures suffi cient expres-
sion of individual prey proteins and simplifi es recovery and 
analysis of positive clones. Coexpression of YFP2 – ERGIC-53 
and the cDNA-YFP1 library resulted in the detection of 1.63% 
yellow fl uorescent COS-1 cells, and YFP PCA can fully ac-
count for the detected signal because few positive cells were 
obtained upon expression of YFP2 – ERGIC-53 or the cDNA-
YFP1 library alone ( Fig. 2 A ). [ID]FIG2[/ID] In the screen, YFP2 – ERGIC-53 
and the cDNA-YFP1 library were transfected at a ratio of 
10:1 to reduce the number of library plasmids transfected per 
cell. This lowered the percentage of positive cells to 0.12% 
(unpublished data). Several hundred YFP-positive cells were 
collected by FACS and prey clones were recovered, 48 of which 
were individually reanalyzed by YFP PCA in COS-1 cells. 
Coexpression with YFP2 – ERGIC-53 resulted in positive YFP 
signals for prey plasmids numbered 17, 32, 33, and 44 ( Fig. 2 B ). 
 Figure 2.  Screening of the cDNA-YFP1 library 
for ERGIC-53 interaction partners. (A) COS-1 
cells were transfected with the indicated bait 
and prey constructs and analyzed by FACS 
as described in Materials and methods. Co-
expression of YFP2 – ERGIC-53 and the cDNA-
YFP1 library resulted in the speciﬁ c detection of 
1.63% YFP positive (YFP + ) cells. In a nonsatu-
rating screen,   500 ﬂ uorescent cells were col-
lected by FACS and total DNA was extracted 
and transformed into bacteria, which resulted 
in the recovery of several hundred prey clones. 
(B) 48 prey clones were randomly selected 
and plasmids were isolated and individually 
assayed by YFP PCA with YFP2 – ERGIC-53 in 
COS-1 cells. Fluorometric analysis revealed that 
prey plasmids 17, 32, 33, and 44 (indicted 
by red boxes) were positive and reconstitute 
ﬂ uorescent YFP when expressed with YFP2 – 
ERGIC-53. Bars represent ﬂ uorometric values 
of a single screening experiment. The thresh-
old for a positive hit was set to 250 arbitrary 
ﬂ uorescence units, which corresponds to a 
  1.5-fold induction in YFP ﬂ uorescence in com-
parison to untransfected cells. (C) Sequence 
analyses identiﬁ ed   1-AT as a cDNA insert in 
all four positive prey plasmids. 
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to proteasomal as well as lysosomal degradation ( Cabral et al., 
2000 ;  Teckman et al., 2001 ). Strikingly, in our YFP PCA, 
neither   1-AT HK nor   1-AT Z bound to ERGIC-53 ( Fig. 3 B ). 
YFP2 –  1-AT Z was expressed at a similar intracellular level as 
YFP2 –  1-AT WT and was not affected by the two inhibitors of 
proteasomal degradation lactacystin and kifunensine. We can-
not rule out the possibility that aggregation decreases the pool 
of soluble, ERGIC-53 binding-competent   1-AT Z , thereby low-
ering the YFP PCA signal. In the case of   1-AT HK , inhibition of 
proteasomal degradation by lactacystin and kifunensine clearly 
increased intracellular levels of YFP2 –  1-AT HK. Although the 
amount of YFP2 –  1-AT HK was thereby restored to that of the 
wild-type construct, the YFP PCA signal was not enhanced 
( Fig. 3 B ). These data suggest that the ERGIC-53 –  1-AT inter-
action is conformation-dependent and supports a function of 
ERGIC-53 in secondary quality control by capturing only na-
tive cargo proteins for ER export ( Ellgaard and Helenius, 2003 ; 
 Appenzeller-Herzog et al., 2005 ). 
 To confi rm that ERGIC-53 captures   1-AT for ER export, 
we analyzed the transport of endogenous   1-AT in HepG2 cells 
in which ERGIC-53 was knocked down by siRNA. Silencing of 
ERGIC-53 for 96 h reduced total ERGIC-53 protein levels to 
below 20% ( Fig. 4 A ). [ID]FIG4[/ID] Intriguingly, the knock down of ERGIC-53 
led to substantial steady-state accumulation of   1-AT inside the 
cell ( Fig. 4 A ). This effect was further analyzed by studying 
transport and secretion of   1-AT in pulse chase experiments 
interaction by performing a YFP PCA with the N156A mutant 
of ERGIC-53 and a triple N70,107,271Q mutant of   1-AT. 
ERGIC-53 N156A is unable to bind to N-linked oligosaccharides 
on glycoproteins ( Appenzeller et al., 1999 ) and   1-AT N70,107,271Q 
remains unglycosylated because of site-directed mutagenesis of 
all three N-glycosylation consensus sites. In comparison to their 
wild-type counterparts, ERGIC-53 N156A and   1-AT N70,107,271Q 
showed a markedly reduced YFP PCA signal ( Fig. 3 A ). These 
fi ndings suggest that ERGIC-53 binds   1-AT in a carbohydrate-
dependent manner. We also analyzed N70Q, N107Q, and N271Q 
single mutants of   1-AT and found that mutagenesis of the sec-
ond N-glycosylation site (N107Q) has the strongest effect on the 
ERGIC-53 –  1-AT interaction ( Fig. 3 A ). This result is in full 
agreement with a previous study showing that the N107Q mu-
tant of   1-AT has a signifi cantly longer intracellular retention 
time than the other mutations ( Samandari and Brown, 1993 ). 
Interestingly, all three N-glycosylation single site mutants have 
similar degradation rates and solubility ( Samandari and Brown, 
1993 ). Hence, the carbohydrate attached at N107 is particularly 
important for ER export. 
 Next, we addressed the conformation specifi city of the 
ERGIC-53 –  1-AT interaction by analyzing two misfolded ver-
sions of   1-AT known as Z (  1-AT Z ) and Hong Kong (  1-AT HK ) 
mutants ( Stoller and Aboussouan, 2005 ). Although   1-AT HK is 
soluble and degraded by ER-associated degradation involving 
the proteasome,   1-AT Z aggregates in the ER and is subjected 
 Figure 3.  ERGIC-53 captures   1-AT in a carbo -
hydrate- and conformation-dependent manner. 
The indicated YFP PCA constructs were ex-
pressed in HeLa cells for 24 (A) and 48 h (B). 
20   M Lactacystin (lact) and 200   M kifunen-
sine (kif) were applied where indicated for 24 h. 
YFP complementation was analyzed by ﬂ uo-
rometric analysis of cell suspensions in micro titer 
plates and expression levels of the different 
constructs were probed by Western blotting 
(WB) using polyclonal antibodies against 
ERGIC-53 and   1-AT. Endogenous ERGIC-53 
functions as an input control. Bars represent 
mean  ± SD ( n = 3) 
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  60 min in +/+ MEFs. ERGIC-53 knockout MEFs secreted in 
the same time only   25% of the newly synthesized   1-AT and 
showed signifi cantly slower conversion of high-mannose to 
complex glycosylated   1-AT ( Fig. 5, A and B ). [ID]FIG5[/ID] A general secre-
tion defect can again be excluded because ERGIC-53 knockout 
MEFs secreted endogenous fi bronectin as effi ciently as wild-
type MEFs ( Fig. 5, A and B ). These results demonstrate that 
  1-AT secretion is signifi cantly delayed without ERGIC-53 but 
that alternative, less effi cient ER export pathways exist. 
 If ERGIC-53 is a transport receptor of   1-AT, reintroduc-
tion of ERGIC-53 should correct the secretion defect of   1-AT 
in ERGIC-53 knockout cells. Indeed, when human ERGIC-53 
was coexpressed with   1-AT, intracellular   1-AT was consider-
ably reduced in   /  MEFs at a steady state ( Fig. 5 C ). More-
over, ERGIC-53 increased the secretion of   1-AT in   /  MEFs 
to the level of +/+ MEFs after a 1-h chase ( Fig. 5, D and E ). 
Hence, overexpression of ERGIC-53 in ERGIC-53 knock out 
MEFs can completely restore   1-AT secretion. These rescue 
experiments clearly establish ERGIC-53 as an intracellular 
transport receptor of   1-AT. Previous studies on ERGIC-53 
function were mainly based on genetic analysis ( Nichols et al., 
1998 ), transport studies with a dominant-negative ER-retained 
mutant of ERGIC-53 ( Vollenweider et al., 1998 ;  Appenzeller 
using [ 35 S]methionine.   1-AT is synthesized as high-mannose 
glycoprotein, undergoes complex glycosylation in the Golgi, 
and is subsequently secreted into the culture medium. In HepG2 
cells transfected with control siRNA, high-mannose   1-AT was 
rapidly converted to its complex glycosylated form and about 
half of the protein was already secreted after a 30-min chase. 
In contrast, in ERGIC-53 – silenced cells,   1-AT remained con-
siderably longer in its high-mannose form and only   15% 
of the protein was secreted after 30 min ( Fig. 4, B and C ). 
The ineffi cient secretion of   1-AT is not caused by a general 
secretion defect because the secretion of endogenous albumin is 
unchanged ( Fig. 4, B and C ). Furthermore, previous studies in 
HeLa cells have already shown that neither depletion nor mis-
localization of ERGIC-53 change the morphology of the secre-
tory pathway or affect overall protein secretion ( Vollenweider 
et al., 1998 ;  Nyfeler et al., 2006 ). Hence, reduced levels of 
ERGIC-53 signifi cantly delay the secretion of   1-AT in a spe-
cifi c manner. 
 To determine if the remaining secretion of   1-AT is caused 
by residual ERGIC-53, we studied the transport of   1-AT 
transfected into mouse embryonic fi broblasts (MEFs) derived 
from ERGIC-53 knockout (  /  ) and wild-type (+/+) mice. 
Pulse chase experiments revealed a half-time of secretion of 
 Figure 4.   1-AT secretion is impaired in ERGIC-53 knock-
down cells. HepG2 cells were transiently transfected for 96 h with 
control and ERGIC-53 – speciﬁ c siRNA duplexes. (A) West ern 
blotting using monoclonal anti – ERGIC-53 and anti – CLIMP-63 
and polyclonal anti –  1-AT antibodies. ERGIC-53 is efﬁ ciently 
silenced, which results in intracellular accumulation of   1-AT. 
CLIMP-63, an ER-resident membrane protein, functions as an 
input control. (B) [ 35 S]methionine pulse chase of endogenous 
  1-AT and albumin. HepG2 cells were labeled for 15 min 
with [ 35 S]methionine and chased for the indicated times, and 
  1-AT and albumin were recovered by immunoprecipitation 
from cell lysates (intracellular) and conditioned medium (extra -
cellular) using anti –  1-AT and anti-albumin antibodies, respec-
tively. (C) The amount of intracellular and extracellular   1-AT 
and albumin was quantiﬁ ed by densitometric scanning of 
the band intensities and the secreted fraction of total protein 
[extracellular/(intracellular + extracellular)] was determined 
for each time point. Bars represent mean  ± SD ( n = 3). Results 
analyzed by paired  t test: NS, P  > 0.05; **, P  < 0.01. 
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 In conclusion, this study not only identifi es an intracellular 
transport receptor of   1-AT but also opens an unprecedented 
avenue to genome-wide screening for protein – protein inter-
actions in the secretory pathway. The successful identifi cation 
of a novel ERGIC-53 cargo protein by YFP PCA – based screening 
of a complex cDNA-YFP1 fusion library provides a general 
strategy to identify novel luminal protein complexes. With nor-
malized libraries and optimized transfection conditions, saturat-
ing and genome-wide screens will be feasible in the near future. 
Further, YFP PCA has a promising potential for high-through-
put screening of chemical and molecular chaperones ( Burrows 
et al., 2000 ) that can rescue conformational defects of   1-AT 
mutants and render them secretion-competent by promoting 
their interaction with ERGIC-53. 
et al., 1999 ), or the characterization of ERGIC-53 – cargo inter-
actions ( Appenzeller et al., 1999 ;  Appenzeller-Herzog et al., 
2005 ;  Nyfeler et al., 2005 ;  Zhang et al., 2005 ). The current 
study provides now direct evidence for active receptor-mediated 
ER export of a soluble secretory protein in mammalian cells. 
Furthermore, our data indicate that transport receptors render 
cargo transport faster and more effi cient, but cargo transport 
is not entirely blocked in their absence.   1-AT may possess 
a second transport receptor or may exit the ER by bulk fl ow to 
a certain extent. The screening approach we described here could 
be equally applied using   1-AT as bait to identify novel cargo 
receptors. With   1-AT, we now identifi ed an attractive model 
secretory protein to study the mechanism of receptor-mediated 
protein export from the ER in detail. 
 Figure 5.  ERGIC-53 is an intracellular trans-
port receptor of   1-AT.   1-AT was transfected 
into wild-type (+/+) and ERGIC-53 knock-
out (  /  ) MEFs and expressed for 24 h. 
(A) [ 35 S]methionine pulse chase of   1-AT and 
endogenous ﬁ bronectin. MEFs were labeled 
with [ 35 S]methionine for 15 min and chased 
for the indicated times, and   1-AT and ﬁ bro-
nectin were recovered by immunoprecipitation 
from cell lysates (intracellular) and conditioned 
medium (extracellular) using anti –  1-AT and 
anti-ﬁ bronectin antibodies, respectively. (B) The 
secreted fraction of   1-AT and ﬁ bronectin was 
quantiﬁ ed as described in  Fig. 4 C . (C)   1-AT 
was coexpressed with human ERGIC-53 in 
ERGIC-53 knockout MEFs (MEF   /  plus 
ERGIC-53). Western blotting was performed 
using polyclonal antibodies against ERGIC-53, 
  1-AT, and CLIMP-63. (D) [ 35 S]methionine pulse 
chase of   1-AT. (E) The secreted fraction of   1-AT 
after a 60-min chase was quantiﬁ ed by densi-
tometric scanning and calculated as in  Fig. 4 
[extracellular/(intracellular + extracellular)]. 
Bars represent mean  ± SD ( n = 3). Results analy -
zed by paired  t test: NS, P  > 0.05; *, P  < 0.05. 
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serum and antibiotics. HepG2 cells (HB-8065; American Type Culture 
Collection) were grown in MEM supplemented with 10% fetal bovine serum 
and antibiotics. HeLa and COS-1 cells were transfected using FuGENE6 
(Roche). HepG2 cells were transfected with control and ERGIC-53 siRNA 
using HiPerfect (QIAGEN) as described previously ( Nyfeler et al., 2006 ). 
MEFs were transfected by electroporation using the Amaxa Nucleofector, 
program T-20, and MEF solution 2 (Amaxa Biosystems).   1-AT and ERGIC-53 
were expressed from pECEM(A1Pi) and pECE(ERGIC-53) ( Schindler et al., 
1993 ), respectively. 
 Immunoblotting 
 Protein samples were prepared by boiling cell suspensions in protein sam-
ple buffer and were separated by SDS-PAGE, transferred to nitrocellulose 
membranes, immunoblotted with the indicated antibodies, and visualized 
by enhanced chemiluminescence (GE Healthcare). 
 PCR screening 
 DNA from heat-killed bacterial transformants was ampliﬁ ed with two prim-
ers that anneal onto the pcDNA3 vector backbone and amplify   1,150 
and   650 bp fragments for pcDNA3(SS-YFP1-MCFD2) and pcDNA3
(SS-HA-MCFD2), respectively. 
 Preparation of wild-type and ERGIC-53 knockout MEFs 
 MEFs were generated from embryos at 13.5 d postcoitus as described pre-
viously ( A. Nagy, 2003 ) by mating heterozygous mice with an ERGIC-53 
knockout allele and transformed with the SV40 large T antigen, and im-
mortalized cell lines were established. 
 [ 35 S]methionine metabolic labeling 
 Cells were deprived of L- methionine for 30 min, pulsed for 15 min with 100   Ci 
[ 35 S]methionine (Perkin Elmer) and chased for the indicated times in culture 
medium containing 10 mM L- methionine. Cells were lysed in 1% Triton 
X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM CaCl 2 , and PMSF, 
and lysates were cleared by centrifugation at 100,000  g for 1 h. The chase 
medium was cleared from cell debris by centrifugation at 20,000  g for 
5 min. Cleared samples were immunoprecipitated with the indicated 
antibodies, immunoprecipitates were separated by SDS-PAGE, and radio-
labeled bands were imaged and quantiﬁ ed using a phosphorimager 
(Molecular Dynamics). 
 Statistical analysis 
 Mean, standard deviation, and  t test were calculated by using Excel 
2002 (Microsoft). A two-tailed, paired  t test was used to calculate the sta-
tistical signiﬁ cance between two indicated samples. P-values  > 0.05 were 
considered not signiﬁ cant and p-values  < 0.05 and  < 0.01 were consid-
ered signiﬁ cant. 
 Online supplemental material 
 Fig. S1 shows the assessment of the human adult liver cDNA-YFP1 library. 
Fig. S2 shows the assessment of plasmid transfection and recovery. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200709100/DC1. 
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